Alicia Shang

Alicia Shang currently serves as Senior Manager of Global Commercial Insights at Amgen, focusing on budget management and insights delivery for bemarituzumab. Prior to this role, Alicia was a Senior Consultant at Nuvera Life Science Consulting from December 2019 to February 2024, where responsibilities included project planning, treatment journey mapping, and commercialization strategies across multiple European markets. Earlier career experiences include positions as a Strategy Consultant and Senior Analyst, as well as a Global Regulatory Intelligence Intern at Alcon, and various research and operational roles. Alicia holds a Master of Public Health in Epidemiology & Regulatory Affairs from Yale School of Public Health and a Bachelor of Science (Honors) in Life Sciences from the National University of Singapore.